Member Info for BuenaVista

Further POINT Biopharma presentations: https://www.pointbiopharma.com/investors#events

February 7: Guggenheim 5th Annual Oncology Conference
- Format: Fireside Chat and 1x1 Meetings
- Webcast link: https://guggenheim.metameetings.net/events/oncology23/general_signin?gpu_only=true

That's a mistake, the date should be February 8.

POINT Biopharma to Participate in Upcoming Investor Conferences
https://www.biospace.com/article/releases/point-biopharma-to-participate-in-upcoming-investor-conferences-february-02-2023/

Published: Feb 02, 2023

INDIANAPOLIS, Feb. 02, 2023 (GLOBE NEWSWIRE) -- POINT Biopharma Global Inc. (NASDAQ: PNT) (the “Company” or “POINT”), a company accelerating the discovery, development, and global access to life-changing radiopharmaceuticals, today announced management will participate in the following upcoming investor conferences:

Guggenheim 5th Annual Oncology Conference
Format: Fireside Chat and 1x1 Meetings
Location: New York, NY
Date: Wednesday, February 8, 2023
Time: 2:10 pm ET

SVB Securities Global Biopharma Conference
Format: Fireside Chat and 1x1 Meetings
Location: Virtual
Date: Thursday, February 16, 2023
Time: 11:20 am ET

Cowen 43rd Annual Health Care Conference
Format: GI/GU Oncology Panel Discussion and 1x1 Meetings
Location: Boston, MA
Date: Tuesday, March 7, 2023
Time: 12:50pm ET

Oppenheimer 33rd Annual Healthcare Investor Conference
Format: Fireside Chat and 1x1 Meetings
Location: Virtual
Date: Monday, March 13, 2023
Time: 8:40am ET

2023 Bloom Burton & Co. Healthcare Investor Conference
Format: Presentation and 1x1 Meetings
Location: Toronto, ON
Dates: Tuesday, April 25 and Wednesday, April 26, 2023

To access the live webcasts of the presentations (if publicly available) please visit the Investors section of the company’s website at https://www.pointbiopharma.com/investors.

About POINT Biopharma Global Inc.
POINT Biopharma Global Inc. is a globally focused radiopharmaceutical company building a platform for the clinical development and commercialization of radioligands that fight cancer. POINT aims to transform precision medicine by combining a portfolio of radiopharmaceutical assets, a seasoned management team, an industry-leading pipeline, in-house manufacturing capabilities, and secured supply for rare medical isotopes like actinium-225 (225Ac) and lutetium-177 (177Lu). POINT’s active clinical trials include FRONTIER, the phase 1 trial for PNT2004, a pan-cancer program targeting fibroblast activation protein-a (FAP-a), and SPLASH, the phase 3 trial for PNT2002 for people with metastatic castration resistant prostate cancer (mCRPC) after second-line hormonal treatment. More information about the SPLASH trial can be found at https://www.splashtrial.com/. Learn more about POINT Biopharma Global Inc. at https://www.pointbiopharma.com/.

Trial has been going for coming on 18 months, but good try with the 2 years.

If there's no further information about the trial before Science Day (personally I think there will be), I'd like to know the answer to the question "Why no DE details yet?" Hopefully someone would ask it and we'd get to hear/read the answer.

Thanks for the clarification SB.

So whoever is buying up shares hasn't reached 3% yet.

There was nothing about the preclinical programmes, so no.

Could it be that one or more pharma companies are buying in, but not all in their own name? Using obscure subsidiaries or friendly institutional investment houses or firms in tax havens or venture capital set ups, etc that will pledge their shares to support the company's takeover bid. Surely a takeover bid would be launchd with some existing holding in Avacta and several disperate holdings all under 3% would provide a good launch pad without revealing their hand?

"The event will include an update on the ongoing preclinical programmes as well as on progress in the ALS-6000-101 "

How can they do any of this without announcing the progress before the event starts? There certainly should be an RNS before Science Day starts.

Nuclear fusion had been and always will be 15 years away.

Hope you burn Terry.

@Mrtwisted
None. Absolutely none whatsoever.

P.S. Binned

Of course they are genuine questions Revoy. Of course they are. Believe you 100%. It's not as if you're trying to waste people's time replying to you with genuine information that you can add to the sum total of nothing that you already know. Of course they are genuine questions, Just like you are a genuine sea lion. Question is, which sea lion are you?

Can you link to the handout please?

I'm hoping for a serious, or any, answer today to the request for a source for what you say.

^ a buy

Yes, I think a bit. Currently 171.4 to buy.

Somebody knows something!

MMs dropping the price for US size buyers?
Traders such as the sea lion taking their profit?